TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: GMT ratio of GMT SCB-2019 over GMT COVID-19 Vaccine Janssen on Day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GMT ratio of GMT SCB-2019 over GMT CoronaVac Vaccine on Day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Degree of rectal hypermobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Frailty Assessment Scale for Heart Failure (FAS-HF) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Clinical Frailty Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in symptoms distress scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gray Matter cortical thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reducing Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of participants receiving triple therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgery Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Calcaneocuboid arthrodesis union
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of participants with abnormal 12-lead electrocardiogram (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative TAR component accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with clinical and parasitological cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of pulmonary surfactant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Length of time to first additional opioid analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total need for additional opioids
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Neuropsychiatric Inventory (NPI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Malondialdehyde (MDA), marker of oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total EHR time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completed appointment rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Same day closure rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Body position on work station
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Function of neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contraceptive Self-Efficacy (CSE) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Beck Scale for Suicidal Ideation (SSI) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diagnostic potential of SEMA4C as a biomarker for breast cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Serum Hepcidin Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: POP-Q
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: POPDI-6 score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Z-score on Combined Digit Symbol Substitution Test (DSST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Oral Health Related Quality of Life (OHRQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Language status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Muscle Strength Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Muscle Strength Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects without any localized or systemic safety events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects with Target Lesion Primary Patency (TLPP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Fall Efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Handgrip Strength Measurement Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants taking up oral PrEP
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of volunteers adhering to oral PrEP
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to oral PrEP uptake
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of Arterial Occlusive Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rate of Serious Arterial Occlusive Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Biochemically validated tobacco cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Change in Systolic Blood Pressure (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HTN Self-Care as reported by H-SCALE
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area Under the Curve (AUC) for Matrine in Saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve for Matrine in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration (Cmax) of Matrine in Saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients remaining on active surveillance at 7 months
Endpoint domain: Mortality/survival
Primary endpoint: Preliminary antitumor activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Musculoskeletal ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Visual Analogue scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Willingness to undergo critical care treatment again based on survival chance
Endpoint domain: Mortality/survival
Primary endpoint: Change in Physical Function (6-Minute Walk Test)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Neck Angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binocular vision and visual function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transcranial magnetic stimulation (TMS)-evoked EEG potentials (TEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of fever (temperature ≥39.0℃)
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of imiquimod versus surgical excision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fiber patency (number of open dialyzer fibers)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dialyzer extraction in FX CorAL dialyzer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognition crystallized composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year Breast Cancer-Specific Survival (BCSS)
Endpoint domain: Mortality/survival
Primary endpoint: Time between birth and onset of seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in mitochondrial ATP production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in redox state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mitochondrial electron flux
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to onset of composite confirmed disability progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Treatment Emergent Adverse Events (TEAEs) and Severity of TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Withdrew Due to Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Columbia Suicide Severity Rating Scale (C-SSRS) Responses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of adipose tissue in the knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (SF-12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Measure pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single vertical pocket
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Anterior Chamber Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in baseline movement quality as measured by the Selective Functional Movement Assessment (SFMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in muscle strength testing as measured by hand held dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in baseline in motor performance as measured by the Single Leg Hop jump distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of the risk-based stratification system implementation - contacted
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Success of the risk-based stratification system implementation - referred
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Success of the risk-based stratification system implementation - navigation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Success of the risk-based stratification system implementation - palliative care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: post-stent removal urinary tract infection
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of recovery in the first postoperative day
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to First Antibiotic Administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in QoL-B RSS
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean daily blood glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants with Treatment-emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Points change of pain evaluation scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time change of up-and-go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle change of range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Points change of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The concentration of serum inflammatory factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Distance of incisors intrusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CIN3+ incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants with side effects in MSCs treatment groups
Endpoint domain: Adverse events/effects
Primary endpoint: CD4+ T cell counts after MSCs transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of patients with objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Local and Systemic Solicited AEs by Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Unsolicited AEs by Severity and Relatedness
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With SAEs Severity and Relatedness
Endpoint domain: Adverse events/effects
Primary endpoint: Binding characteristics of 64Cu-DOTA-ECL1i
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Imaging characteristics of 64Cu-DOTA-ECL1i
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Imaging reproducibility of 64Cu-DOTA-ECL1i PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total motile sperm count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Time in target blood glucose range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of new abnormal myocardial blood flow reserve (MBFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart Failure Events
Endpoint domain: Adverse events/effects
Primary endpoint: Respiratory frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vascular density (VD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: peripapillary retinal nerve fiber (RNFL) thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Treatment adherence rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Differences in sleep duration between the first and eighth weeks
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Overall Survival Benefit
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants Who do Not Engage in Twitter Activities
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Emotional Valence Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oral microbiome changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intestinal microbiome changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Growth Differentiation Factor-15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute confusional state/Delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Atrial fibrillation detection sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Data accuracy of inter-beat-intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of ECG signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Distribution of HH-120 in the nasal cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local drug concentration in nasal and nasopharyngeal swab samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence Rate of Major Adverse Cardiovascular Events (MACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: blood cell count (CBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: kidney functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of patients with DLTs
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Benefit Analgesia Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pulmonary Functions Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Radiological scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedure feasibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Birth weight at time of Delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of cholesterol testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum functional AAT (fAAT) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Total Huntingtin Protein (tHTT) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with TEAEs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Abnormal laboratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in sleep duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change of lung microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Strength of quadriceps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Response to selenium treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of sexually transmitted HIV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: The uptake of risk informed biomedical HIV prevention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: The cost of transmissible HIV averted
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Right ventricle longitudinal strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Right ventricle infundibulum diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of ventricular extrasystoles > 500
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of successful taper
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of recipients with sustained microfilarial response at month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in provider knowledge of smoking cessation treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in provider self-efficacy to deliver evidence-based smoking cessation treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of women diagnosed with gestational diabetes mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Post operative myocardial injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in depression treatment use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CMV virological clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Participants with Abnormal Laboratory Assessments, 12-Lead Electrocardiogram (ECG), and Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete closure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of grade III-IV acute graft-versus-host disease (GVHD)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of extensive chronic GVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Treatment related mortality (TRM)
Endpoint domain: Mortality/survival
Primary endpoint: Change in bisphenols (BPA and BPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LEN and F/TDF Persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and frequency of dose limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Complete response (CR) rate for MDS and CMML-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Overall response rate (ORR) for MDS and CMML failure to prior HMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Complete remission with incomplete blood recovery (CRi) for r/r AML
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Minimal residual disease (MRD) status for newly diagnosed AML
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: sexual dysfunction symptom severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MDS-UPDRS Part III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score at the Short Form of Postural Assessment Scale for Stroke Patients (SFPASS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of pathogens in HFMD children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes